Since HIV viral-load testing is the best tool to enable early detection of therapeutic failure, unrecognized virological failure along with selection and accumulation of drug resistance have been ...

The study evaluated the efficacy and safety of Dovato in 230 antiretroviral treatment-naïve individuals with advanced HIV.

As the science stands, the vast majority of the roughly eight million people in South Africa living with HIV will have to get ...

Patients presenting to emergency departments with opioid overdose have high rates of hepatitis C virus (HCV) infection, ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today ...

From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million ...

The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...

Highly effective treatments for HIV have existed since the mid-1990s. But while these treatments keep people healthy, we do not yet have a safe and scalable way to completely rid the body of the virus ...

The HIV estimates, which are released on an annual basis using the Spectrum Estimation and Projection Package Model, revealed that about 79 627 men and 148 911 women are living with HIV in Namibia.

HONG KONG SAR - Media OutReach Newswire – 12 November 2024 - Immuno Cure BioTech (" Immuno Cure "), a clinical-stage ...

A post-hoc analysis of the study showed DTG/3TC was non-inferior to 3-drug therapy regardless of the participant’s baseline viral load. These data were presented at HIV Glasgow 2024, being held in ...